The impact of sodium-glucose cotransporter-2 inhibitors on cardiac function

Eur J Intern Med. 2024 Apr:122:130-131. doi: 10.1016/j.ejim.2024.02.007. Epub 2024 Feb 19.

Authors

I-Wen Chen¹, Hsiu-Lan Weng², Kuo-Chuan Hung³

Affiliations

¹ Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan city, Taiwan, ROC.
² Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan, ROC.
³ Department of Anesthesiology, Chi Mei Medical Center, No.901, ChungHwa Road, YungKung Dist, Tainan city 71004, Taiwan, ROC. Electronic address: ed102605@gmail.com.

PMID: 38378343
DOI: 10.1016/j.ejim.2024.02.007

No abstract available

Keywords: Cardiac remodeling; Heart failure; Meta-analysis; SGLT2i.

Publication types

Letter

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucose
Heart Failure*
Humans
Sodium
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors
Glucose
Sodium